Publications by authors named "Branko Simic"

Claim this Profile
C
CRISPR-clear imaging of melanin-rich B16-derived solid tumors.
Rajib Schubert, Taegeun Bae, Branko Simic, Sheena N Smith, Seong-Ho Park

Commun Biol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sortase-Mediated Site-Specific Conjugation and Zr-Radiolabeling of Designed Ankyrin Repeat Proteins for PET.
Rachael Fay, Imre Törő, Anna-Lena Schinke, Branko Simic, Jonas V Schaefer

Mol Pharm· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies.
Alexander Akhmedov, Margot Crucet, Branko Simic, Simon Kraler, Nicole R Bonetti

Cardiovasc Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody.
Sheena N Smith, Rajib Schubert, Branko Simic, Dominik Brücher, Markus Schmid

Proc Natl Acad Sci U S A· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NO-donor MPC-1011 stimulates angiogenesis and arteriogenesis and improves hindlimb ischemia via a cGMP-dependent pathway involving VEGF and SDF-1α.
Brigida Gomes de Almeida Schirmer, Margot Crucet, Simona Stivala, Goran Vucicevic, Luciola da Silva Barcelos, Branko Simic

Atherosclerosis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase.
Branko Simic, Pavani Mocharla, Margot Crucet, Elena Osto, Adelheid Kratzer

Atherosclerosis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin.
Susan Kühnast, Sam J L van der Tuin, José W A van der Hoorn, Jan B van Klinken, Branko Simic

Eur Heart J· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptor protein p66(Shc) mediates hypertension-associated, cyclic stretch-dependent, endothelial damage.
Remo D Spescha, Martina Glanzmann, Branko Simic, Fabienne Witassek, Stephan Keller

Hypertension· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targets to raise HDL in patients at risk or with coronary artery disease.
Thomas F Lüscher, Arnold von Eckardstein, Branko Simic

Curr Vasc Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Torcetrapib impairs endothelial function in hypertension.
Branko Simic, Matthias Hermann, Sidney G Shaw, Laurent Bigler, Urs Stalder

Eur Heart J· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis